Company
United StatesPublic company, NASDAQ: GILDGilead Sciences Inc (NASDAQ: GILD), Seattle, WA – FDA Inspections
Inspection records and compliance data for Gilead Sciences Inc in Seattle, Washington. 1 FDA inspection on record, last inspected March 06, 2014. Publicly traded as NASDAQ: GILD.
Company Profile
This profile covers Gilead Sciences Inc based in Seattle, Washington, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected March 6, 2014.
Most cited issue areas
- General responsibilities of sponsors1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 6, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 876903 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Gilead Sciences Inc
Stock ticker
GILD
Exchange
NASDAQ
Share price
$167.53
Market cap
$207.8B
Price as of
November 6, 2026
FEI Number
3008329365
Address
199 E Blaine St, Seattle, Washington 98102, United States
Country
United States
ID: ca09686b-26d2-4ab0-8021-d6b3031534c7